Nls pharmaceutics company update and webcast today postponed

Nls to webcast its event on thursday, july 6, 2023, at 11:00 am et zurich, switerland / accesswire / june 30, 2023 / nls pharmaceutics ltd. (nasdaq:nlsp)(nasdaq:nlspw) ("nls" or the "company"), a swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced it will postpone its webcast previously scheduled for today due to important developments impacting the timing of the company update.
NLSP Ratings Summary
NLSP Quant Ranking